BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26616803)

  • 1. [Differences between colorectal cancer patients and healthy people in fecal microbiota and metabolites].
    Wang X; Wang J; Rao B; Deng L; Huang Y; Zeng G; Chen C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1106-10. PubMed ID: 26616803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults.
    Weir TL; Manter DK; Sheflin AM; Barnett BA; Heuberger AL; Ryan EP
    PLoS One; 2013; 8(8):e70803. PubMed ID: 23940645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer.
    Ohigashi S; Sudo K; Kobayashi D; Takahashi O; Takahashi T; Asahara T; Nomoto K; Onodera H
    Dig Dis Sci; 2013 Jun; 58(6):1717-26. PubMed ID: 23306850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer.
    Ocvirk S; Wilson AS; Posma JM; Li JV; Koller KR; Day GM; Flanagan CA; Otto JE; Sacco PE; Sacco FD; Sapp FR; Wilson AS; Newton K; Brouard F; DeLany JP; Behnning M; Appolonia CN; Soni D; Bhatti F; Methé B; Fitch A; Morris A; Gaskins HR; Kinross J; Nicholson JK; Thomas TK; O'Keefe SJD
    Am J Clin Nutr; 2020 Feb; 111(2):406-419. PubMed ID: 31851298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
    Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
    Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
    Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
    Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
    Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
    Amitay EL; Krilaviciute A; Brenner H
    Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus.
    Yang Y; Han Z; Gao Z; Chen J; Song C; Xu J; Wang H; Huang A; Shi J; Gu J
    Chin Med J (Engl); 2023 Dec; 136(23):2847-2856. PubMed ID: 36959686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans.
    Ou J; Carbonero F; Zoetendal EG; DeLany JP; Wang M; Newton K; Gaskins HR; O'Keefe SJ
    Am J Clin Nutr; 2013 Jul; 98(1):111-20. PubMed ID: 23719549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral microbiota in colorectal cancer is distinctive and predictive.
    Flemer B; Warren RD; Barrett MP; Cisek K; Das A; Jeffery IB; Hurley E; O'Riordain M; Shanahan F; O'Toole PW
    Gut; 2018 Aug; 67(8):1454-1463. PubMed ID: 28988196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of fecal microbiota for early-stage detection of colorectal cancer.
    Zeller G; Tap J; Voigt AY; Sunagawa S; Kultima JR; Costea PI; Amiot A; Böhm J; Brunetti F; Habermann N; Hercog R; Koch M; Luciani A; Mende DR; Schneider MA; Schrotz-King P; Tournigand C; Tran Van Nhieu J; Yamada T; Zimmermann J; Benes V; Kloor M; Ulrich CM; von Knebel Doeberitz M; Sobhani I; Bork P
    Mol Syst Biol; 2014 Nov; 10(11):766. PubMed ID: 25432777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults.
    Watanabe D; Murakami H; Ohno H; Tanisawa K; Konishi K; Todoroki-Mori K; Tsunematsu Y; Sato M; Ogata Y; Miyoshi N; Kubota N; Kunisawa J; Wakabayashi K; Kubota T; Watanabe K; Miyachi M
    BMC Microbiol; 2021 Jun; 21(1):196. PubMed ID: 34182940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of daily intake of pomegranate juice on fecal microbiota and feces metabolites from healthy volunteers.
    Mosele JI; Gosalbes MJ; Macià A; Rubió L; Vázquez-Castellanos JF; Jiménez Hernández N; Moya A; Latorre A; Motilva MJ
    Mol Nutr Food Res; 2015 Oct; 59(10):1942-53. PubMed ID: 26228065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fecal microbial markers in colorectal cancer detection.
    Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
    Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.
    Sakai SA; Aoshima M; Sawada K; Horasawa S; Yoshikawa A; Fujisawa T; Kadowaki S; Denda T; Matsuhashi N; Yasui H; Goto M; Yamazaki K; Komatsu Y; Nakanishi R; Nakamura Y; Bando H; Hamaya Y; Kageyama SI; Yoshino T; Tsuchihara K; Yamashita R
    Front Cell Infect Microbiol; 2022; 12():925444. PubMed ID: 36189350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations.
    Sinha R; Ahn J; Sampson JN; Shi J; Yu G; Xiong X; Hayes RB; Goedert JJ
    PLoS One; 2016; 11(3):e0152126. PubMed ID: 27015276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.